EB
Everest Biolabs, Inc.
SEC filingBiotechnology · Waltham, MA
Amount raised$4.4Msold at filing
Total offering$5.7M$1.3M still open
Investors in the raise7count reported to the SEC
FiledMar 11, 2026first sale Feb 25, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David FreedmanExecutive Officer, Director
Paul MeisterDirector
Vinit NijhawanDirector
George DaaboulExecutive Officer, Director
David WaltDirector
Executive officers, directors and promoters as listed on the Form D.